A Narrative Review of Implementing Precision Oncology in Metastatic Castration-Resistant Prostate Cancer in Emerging Countries

The therapeutic landscape of metastatic castration-resistant prostate cancer (mCRPC) has evolved considerably with the introduction of newer agents, such as poly-ADP ribose polymerase (PARP) inhibitors targeting DNA damage repair mutations. Combining and sequencing novel and existing therapies appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bazarbashi, Shouki, Su, Wen-Pin, Wong, Siew W., Singarachari, Ramanujam A., Rawal, Sudhir, Volkova, Maria I., Bastos, Diogo A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593077/
https://www.ncbi.nlm.nih.gov/pubmed/34236692
http://dx.doi.org/10.1007/s40487-021-00160-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593077/
https://www.ncbi.nlm.nih.gov/pubmed/34236692
http://dx.doi.org/10.1007/s40487-021-00160-6

Ejemplares similares